| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |